Tianjin Dexiang Biotechnology Co., Ltd.(hereinafter referred to as "Dexbio") was established on December 16, 2011. Located in the Binhai New Area, the first national comprehensive reform and innovation zone approved by the State Council, it is a key investment project in Tianjin Economic-Technological Development Area (TEDA). With a registered capital of 30 million RMB and a total project investment exceeding 100 million RMB, Dexbio is a high-tech enterprise integrating research and development, production, and sales in the field of in vitro diagnostics.